PRESS-RELEASE filed Aug 5, 2026 at 16:00 ET
Arcutis reported Q2 2026 product revenue of $129.9M (+59% YoY) and net income of $15.0M ($0.11 EPS), a significant turnaround from a net loss of -$15.9M in Q2 2025. The company raised full-year 2026 net product sales guidance from $480-495M to $525-540M, reflecting strong ZORYVE demand and improved gross-to-net pricing. Despite the EPS miss vs consensus ($0.11 actual vs $0.05 estimate, a +120% beat), the stock is likely to react positively to the revenue beat, raised guidance, and sustained positive operating cash flow of $12.6M.